|
HS Code |
936082 |
| Name | Menatetrenone |
| Other Names | Vitamin K2, MK-4 |
| Chemical Formula | C31H40O2 |
| Molecular Weight | 444.65 g/mol |
| Appearance | Yellow crystalline powder |
| Cas Number | 863-61-6 |
| Therapeutic Use | Treatment of osteoporosis and vitamin K deficiency |
| Mechanism Of Action | Promotes gamma-carboxylation of osteocalcin and other proteins |
| Route Of Administration | Oral |
| Solubility | Soluble in fats and organic solvents |
| Melting Point | 53-54°C |
| Atc Code | A11CC04 |
As an accredited Menatetrenone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Menatetrenone is packaged in an amber glass vial containing 1 gram, sealed, with a tamper-evident cap and labeled for laboratory use. |
| Shipping | Menatetrenone is shipped in tightly sealed, light-resistant containers, typically under nitrogen or argon atmosphere to prevent oxidation. It is transported at controlled room temperature or refrigerated conditions, depending on manufacturer guidelines, and clearly labeled as a chemical reagent. Appropriate documentation and hazard labeling ensure compliance with international shipping regulations. |
| Storage | Menatetrenone should be stored in a tightly closed container, protected from light, moisture, and air. Keep it at a controlled room temperature, typically between 2°C and 8°C (refrigerated). Ensure the storage area is cool, dry, and well-ventilated. Avoid sources of heat and incompatibles. Follow all relevant safety guidelines and local regulations for storage of chemical substances. |
|
Purity 98%: Menatetrenone with 98% purity is used in osteoporosis treatment formulations, where enhanced bone mineral density is achieved. Molecular weight 444.65 g/mol: Menatetrenone of molecular weight 444.65 g/mol is used in pharmaceutical tablet production, where precise dosing and bioavailability are ensured. Melting point 53–54°C: Menatetrenone with a melting point of 53–54°C is used in softgel encapsulation, where optimal processability and stability are maintained. Particle size D90 <10 μm: Menatetrenone with particle size D90 less than 10 μm is used in injectable drug preparations, where rapid dissolution and absorption are facilitated. Stability temperature ≤25°C: Menatetrenone stable up to 25°C is used in long-term storage conditions, where shelf-life extension and potency retention are provided. Viscosity 200–300 cP: Menatetrenone with a viscosity range of 200–300 cP is used in oil-based nutritional supplements, where homogenous dispersion and consistent dosing are enabled. UV absorbance 248 nm: Menatetrenone exhibiting UV absorbance at 248 nm is used in quality control assays, where accurate quantification and verification are achieved. Water content <0.2%: Menatetrenone with water content below 0.2% is used in lyophilized formulations, where product stability and reduced hydrolysis risk are assured. Heavy metal content <10 ppm: Menatetrenone with heavy metal content under 10 ppm is used in clinical grade preparations, where safety and regulatory compliance are maintained. Residual solvent <500 ppm: Menatetrenone with residual solvent below 500 ppm is used in GMP-compliant pharmaceutical manufacturing, where product purity and patient safety are improved. |
Competitive Menatetrenone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Menatetrenone, better known as MK-4, stands out among vitamin K2 supplements. This version of vitamin K2 gets a lot of attention from researchers and physicians due to its unique structure and benefits inside the body. If you have ever wondered what sets one vitamin K2 supplement apart from another, or why some products carry the term “MK-4,” Menatetrenone opens the door to that discussion. People curious about bone health, cardiovascular support, and even new approaches in osteoporosis management see this product as a real contender in nutritional science.
Vitamin K exists in several forms. The most familiar is K1, found in green vegetables. Then you get K2, which splits into various subtypes called menaquinones: MK-4, MK-7, and so on. Menatetrenone specifically refers to MK-4. Scientists have spent years mapping out how MK-4 moves through the human body, revealing differences in absorption, the way the liver processes it, and eventual delivery to bones and arteries.
MK-4’s chemical structure makes it smaller and more versatile compared to the longer-chain MK-7. That structure gives it different effects and activity in tissues. Supplements that use Menatetrenone deliver this compound in carefully measured doses, with purity and stability playing a leading role in the product’s final value.
Companies usually sell Menatetrenone as tablets, capsules, or powders. Each dose contains MK-4—the amount measured in micrograms or milligrams. Many supplements stick closely to doses used in Japanese osteoporosis research, which often start around 45 mg per day. That’s much higher than the amount most people get from food.
The manufacturing process affects quality. Dietary supplement makers sourcing Menatetrenone select pharmaceutical-grade raw materials and test each batch for contaminants and potency. The powder itself appears yellow, and the finished product maintains stability under recommended storage conditions. That’s not just about shelf life; purity keeps integrity intact throughout the product’s journey from factory to medicine cabinet.
Not all vitamin K2 supplements mention “Menatetrenone” or “MK-4.” It makes a real difference. MK-7 supplements, for example, linger longer in circulation—sometimes for days—while MK-4 works in a concentrated burst and clears quicker. These characteristics influence everything from dosing recommendation to health application.
Menatetrenone takes center stage in activating certain proteins that depend heavily on vitamin K. Two well-known ones are osteocalcin, which supports calcium placement in bones, and matrix Gla-protein, which patrols arteries to keep calcium away from vessel walls. If either goes missing or stays inactive, the body pays a price, usually in weaker bones or stiffer arteries.
MK-4, unlike its cousin MK-7, gets made right inside human tissues. Organs transform vitamin K1 into MK-4, suggesting the body prefers MK-4 for rapid, localized effects. Researchers point out that in Japanese medicine, Menatetrenone often finds a place in osteoporosis treatment regimens. Emerging studies link regular MK-4 use to increases in bone mineral density and reduction in fracture risk among postmenopausal women.
My interest in bone health started with an athletic background—I’ve learned firsthand how crucial strong bones are. Seeing X-rays of hairline fractures gave me a keen appreciation for nutrients like vitamin K2. Menatetrenone isn’t some miracle cure, but the way it works within calcium metabolism caught my attention. By promoting osteocalcin activity, MK-4 helps bones lay down strong, organized mineral structures.
Researchers also keep an eye on arterial health. Vascular calcification—where calcium lands in the wrong place—predicts heart problems years in advance. Studies in animals and preliminary work in humans suggest that Menatetrenone upregulates matrix Gla-protein, the “bodyguard” that stops calcium deposits in vessel walls. The result isn’t just healthier arteries, but possibly lower risk of high blood pressure and cardiovascular disease.
Safety plays an important part. Menatetrenone has an established record in Japan, where doctors prescribe it for osteoporosis under medical supervision. Reports of side effects remain minimal when taking recommended doses. While vitamin K interacts with blood-thinning medications like warfarin, most healthy adults tolerate Menatetrenone without trouble.
Many supplement labels list “vitamin K2" without specifying which subtype sits inside. That misleads people shopping for real benefits. MK-4 (Menatetrenone) and MK-7 stand as the two dominant players. They both activate vitamin K-dependent proteins, but their behavior in the bloodstream and tissues shows clear differences.
MK-7 typically claims a longer half-life. After you take a capsule, it circulates longer—days rather than hours. MK-4, on the other hand, clears from the blood quickly but acts rapidly in tissues. Some studies suggest the quick burst of MK-4 may trigger biological pathways that extended-release MK-7 cannot reach as intensely, especially in bone turnover or cardiovascular remodeling.
Food sources diverge, too. MK-4 shows up naturally in animal products—meat, eggs, dairy—while MK-7 dominates in fermented soy products such as natto. If someone avoids animal foods, their natural MK-4 intake drops, opening the door to possible deficiency.
Supplement pricing signals another difference. Manufacturing MK-4 demands strict quality control to ensure no synthetic by-products remain. Some products dilute MK-4 concentrations or cut corners in purity, but established brands set a higher standard. This focus on clean, standardized Menatetrenone helps consumers avoid subpar products that fail to deliver measurable effects.
People reach for Menatetrenone for diverse reasons. Older adults with osteoporosis see it as a way to support bone density. Athletes want to preserve healthy bones through intense training. Those at risk for artery calcification aim for vascular health. Doctors in Japan prescribe doses around 45 mg daily—much higher than the microgram amounts found in most multivitamins—using this approach as part of approved medical therapy.
Meeting nutritional needs through food works best. Yet the modern diet makes that hard, especially with less organ meat and reduced egg intake. MK-4 supplements step in where natural intake falls short. Consistency in dosage, paired with medical input for those on anticoagulants, makes a difference in both safety and outcome.
Choosing a supplement with Menatetrenone offers control over intake, but not every brand delivers the same quality. Clinicians and pharmacists recommend verifying third-party testing, seeking out transparent ingredient labels, and checking for pharmaceutical-grade sourcing. That extra effort pays dividends over time, especially for people managing chronic conditions or pursuing long-term vitality.
Not all supplements stand the test of scientific scrutiny. The case for Menatetrenone grew out of real-world clinical practice, most notably in Japan’s long-term management of osteoporosis. Decades of monitoring fracture rates, bone density measures, and patient quality of life built a profile for MK-4 that other vitamin variants rarely match.
The trend in Western countries still favors calcium and vitamin D. While both prove essential, neither addresses the right placement of calcium—into bone, not arteries. That’s where MK-4’s unique activity kicks in. By improving the carboxylation of proteins, Menatetrenone guides calcium into the right compartments, filling a gap that calcium or vitamin D alone can't bridge.
Large-scale nutrition surveys suggest widespread K2 deficiency, particularly among older adults. The reduced intake of animal-based foods and processed dietary habits reduce exposure. In this landscape, Menatetrenone represents not just a supplement, but a way to restore balance in the face of changing dietary patterns.
Bioavailability, or the body’s ability to absorb and use a nutrient, separates effective supplements from those that waste money. Menatetrenone’s naturally occurring form grants it high affinity for tissues that matter, especially bone and arterial lining. I’ve worked with clients who struggled with low bone density despite good calcium and vitamin D intake—adding Menatetrenone often became a real turning point.
Supplement brands with strict manufacturing controls preserve purity and potency. Heat, moisture, or light can degrade MK-4, so packaging and proper storage matter. Softgel forms, encapsulated in oil, allow for steadier absorption, while tablets require high-quality fillers to avoid breakdown before the vitamin is absorbed.
Testing by independent labs weeds out impurities and verifies label claims. This keeps the market honest. With no global standard in place for vitamin K2 quality, consumers rely on certifications and transparency in sourcing. In my experience, the extra dollar spent on a verified product saves hassle and risk long-term.
Groups with the most to gain include postmenopausal women, men at risk for cardiovascular disease, and anyone with a history of bone fractures. People on certain medications or with metabolic conditions such as diabetes may find their K2 needs higher than the average adult. Lifestyle factors—such as a diet low in animal foods—point to an increased need, though individualized guidance works best.
Professional athletes know bone stress well. Whether in running, basketball, or gymnastics, microtrauma accumulates over time. The role of Menatetrenone in encouraging bone repair has caught the eye of sports nutritionists. Recovery, rehabilitation, and proactive strengthening all rest on the shoulders of these finely tuned nutrients.
There’s also optimism around Menatetrenone for dental health. As dental enamel forms and repairs, vitamin K2-dependent proteins come into play, guiding minerals exactly where needed. Pediatricians and dentists alike explore the role of MK-4 in supporting dental development, though more research remains necessary before specific guidelines land in textbooks.
No supplement exists in a vacuum. While Menatetrenone’s safety profile looks strong, individuals on warfarin or similar blood thinners need medical advice before adding any vitamin K2 supplement. MK-4’s short half-life gives doctors flexibility in managing dosing adjustments compared to the slower-degrading MK-7. Otherwise, reported side effects stay rare, typically mild if they appear at all.
Public awareness remains lower than it should be. People often confuse vitamin K1 (used for blood clotting) with K2’s far-reaching effects outside the liver. Educational gaps persist, leaving patients and caregivers guessing or defaulting to low-quality over-the-counter products. Pharmacists, nutritionists, and healthcare providers who stay grounded in the latest science serve as bridges, guiding consumers to evidence-backed decisions.
Walking through supplement aisles or scrolling through online stores reveals a maze of choices. Menatetrenone, as MK-4, occupies a special position. Its research base spans decades. Physicians trust it enough to prescribe pharmaceutical-grade versions in regulated healthcare systems. The majority of vitamins face less scrutiny.
Unlike MK-7, Menatetrenone derives mainly from animal-based sources, echoing traditional dietary patterns that fell off with the rise of processed foods. I often see people surprised at how much their grandparents’ diets—rich in eggs, organ meats, and full-fat dairy—resembled modern recommendations for K2 intake. Supplements like Menatetrenone let us reclaim that nutritional heritage, even when daily routines keep us far from the farm.
From a user’s standpoint, clear labeling, reliable sourcing, and honest marketing win trust. Menatetrenone’s track record in both clinical trials and real-world settings brings peace of mind unmatched by many newer compounds. People appreciate accountability—knowing exactly what goes into their bodies—especially once they experience tangible benefits like stronger bones or more resilient joints.
Moving forward, more work remains in demystifying Menatetrenone. Many people learn about it late—after a fracture or a brush with calcified arteries. Healthcare providers, manufacturers, and educators can change that story through outreach, better labeling, and continued research. As someone passionate about personal health advocacy, I see opportunities in workshops, accessible infographics, and partnerships with medical professionals to build broader understanding.
Regulators could help by setting clear standards for supplement labeling, requiring precise indication of "MK-4" content and verifying purity claims. This helps consumers make better decisions amid a sea of ambiguity. Public health campaigns could feature MK-4’s role alongside calcium and vitamin D, shifting the spotlight onto comprehensive bone and cardiovascular care.
Continued investment in clinical trials, especially long-term studies in diverse populations, expands the knowledge base and sharpens dosing guidelines. Nutrition experts and doctors who adapt to emerging research remain vital sources of practical advice for families navigating aging, athletic performance, or chronic health concerns.
Menatetrenone stands as a key player among nutritional tools for bone strength and arterial health. Unlike many supplements, its legacy reflects robust research, clinical backing, and consistent anecdotal support from those who use it. As nutritional landscapes change and chronic disease rates climb, products like Menatetrenone deliver targeted solutions where routine dietary measures may fall short.
As our understanding of the interplay between nutrients and cellular pathways grows, expect conversations around Menatetrenone to grow louder, better informed, and more action-oriented. Personal experience, scientific rigor, and responsible manufacturing all push this compound to the forefront of effective, modern supplementation. People looking to close nutritional gaps, promote long-term resilience, and add value to their daily health routines find Menatetrenone a powerful ally.
The journey toward optimal bone and vascular health begins with knowledge and ends with tailored action. For many, Menatetrenone serves as an accessible, science-supported step along that path.